Related Experiment Video
Updated: Jan 28, 2026

06:05
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
1.6K
What Every Neuropathologist Needs to Know: Update on cIMPACT-NOW.
Gabrielle A Yeaney1, Daniel J Brat2
1Department of Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
Journal of Neuropathology and Experimental Neurology
|March 5, 2019
Summary
The consortium to inform molecular and practical approaches to CNS tumor taxonomy (cIMPACT-NOW) bridges molecular advances and clinical practice between World Health Organization (WHO) updates. This review details cIMPACT-NOW
Area of Science:
- Neuro-oncology
- Molecular Pathology
- Cancer Classification
Background:
- The World Health Organization (WHO) classification of central nervous system (CNS) tumors is the standard for diagnosis and grading.
- Rapid molecular pathogenesis discoveries necessitate faster integration into clinical practice than current WHO update cycles allow.
Purpose of the Study:
- To review the progress made by the consortium to inform molecular and practical approaches to CNS tumor taxonomy-not official WHO (cIMPACT-NOW) working committees.
- To highlight advancements in CNS tumor classification and grading informed by molecular insights.
Main Methods:
- Review of progress from three separate cIMPACT-NOW working committees.
- Analysis of challenges and solutions in CNS tumor classification and grading.
Main Results:
- Significant progress has been made by cIMPACT-NOW committees in addressing classification and grading challenges.
- Integration of molecular data into CNS tumor taxonomy is advancing.
Conclusions:
- cIMPACT-NOW is crucial for bridging the gap between molecular discoveries and clinical application in CNS tumor classification.
- Continued efforts are needed to refine and implement molecularly informed diagnostic criteria for CNS tumors.

